Cargando…
Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus
Type 2 diabetes is associated with increased risk for the development of cardiovascular disease (CVD) secondary to hyperglycemia’s toxicity to blood vessels. The escalating incidence of CVD among patients with type 2 diabetes has prompted research into how lowering glycated hemoglobin (HbA(1c)) may...
Autores principales: | Palumbo, Pasquale J, Wert, Jonathan M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2828107/ https://www.ncbi.nlm.nih.gov/pubmed/20191079 |
Ejemplares similares
-
Stem cell therapy for type 1 diabetes mellitus: a review of recent clinical trials
por: Couri, Carlos Eduardo Barra, et al.
Publicado: (2009) -
Prevalence of lean type 2 diabetes mellitus in recently diagnosed type 2 diabetes mellitus patients
por: Chaudhary, Prateek, et al.
Publicado: (2013) -
Comparison of education group strategies and home visits in type 2
diabetes mellitus: clinical trial
por: dos Santos, Jéssica Caroline, et al.
Publicado: (2017) -
The impact of hyperglycemia on urinary albumin excretion in recent onset diabetes mellitus type II
por: Nikolaidou, Barbara, et al.
Publicado: (2020) -
Clinical and humanistic impact of pharmacotherapeutic follow-up in patients with type 1 diabetes mellitus treated judicially
por: Mendonça, Thays S., et al.
Publicado: (2022)